GeneNews Diagnostics Launches ColonSentry in Malaysia

GeneNews Limited, an Ontario-based molecular diagnostics company, announced the commercial launch of ColonSentry, a test to determine a person’s current risk for colorectal cancer, in Malaysia through GeneNews Diagnostics Sdn. Bhd. GeneNews Diagnostics is a privately-held Malaysian company that will work with GeneNews Limited to commercialize ColonSentry in Malaysia and elsewhere in Southeast Asia. GeneNews Limited develops blood-based biomarker tests for the early detection of diseases and personalized health management.